Serevent and Sumatriptan succinate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Serevent (salmeterol xinafoate) and Sumatriptan succinate (sumatriptan succinate). Common drug interactions include pyrexia among females.

The phase IV clinical study analyzes what interactions people have when they take Serevent and Sumatriptan succinate. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Serevent?

Serevent has active ingredients of salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 15,586 Serevent users. Check the latest studies of Serevent.

What is Sumatriptan succinate?

Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 9,731 Sumatriptan succinate users. Check the latest studies of Sumatriptan succinate.



On Jul, 09, 2026

13 people who take Serevent and Sumatriptan succinate together, and have interactions are studied.

Serevent and Sumatriptan succinate drug interactions.

What are the common drug interactions of Serevent and Sumatriptan Succinate, by gender? *:

female:

  1. Pyrexia (fever)
  2. Chills (felling of cold)
  3. Pneumonia
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Uveitis (inflammation of the uvea)
  6. Alopecia (absence of hair from areas of the body)
  7. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  8. Hypersensitivity
  9. Lower respiratory tract infection
  10. Trigger finger

male:

n/a

What are the common drug interactions of Serevent and Sumatriptan Succinate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abortion spontaneous (naturally occurring miscarriage)
  2. Anaphylactic reaction (serious allergic reaction)
  3. Clonus (series of involuntary, rhythmic, muscular contractions and relaxations)
  4. Drug ineffective
  5. Emotional distress
  6. Hyperhidrosis (abnormally increased sweating)
  7. Hyperreflexia (overactive or over responsive reflexes)
  8. Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
  9. Hypoxia (low oxygen in tissues)
  10. Maternal exposure during pregnancy (use of substance during pregnancy)

40-49:

  1. Conjunctivitis (pink eye)

50-59:

n/a

60+:

  1. Chills (felling of cold)
  2. Fatigue (feeling of tiredness)
  3. Pneumonia
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Uveitis (inflammation of the uvea)
  6. Alopecia (absence of hair from areas of the body)
  7. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  8. Hypersensitivity
  9. Lower respiratory tract infection
  10. Trigger finger

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 10 people, 76.92%
  2. Primary Immunodeficiency Syndrome: 7 people, 53.85%
  3. Uterine Contractions During Pregnancy: 1 person, 7.69%
  4. Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 1 person, 7.69%
  5. Nausea And Vomiting: 1 person, 7.69%
  6. Nausea (feeling of having an urge to vomit): 1 person, 7.69%
  7. Morning Sickness (sickness in morning during pregnancy): 1 person, 7.69%
  8. Hyperemesis Gravidarum (a condition characterized by severe nausea, vomiting, weight loss, and electrolyte disturbance): 1 person, 7.69%
  9. Body Temperature Increased: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Serevent and Sumatriptan succinate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Serevent and Sumatriptan succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Serevent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sumatriptan succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Serevent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sumatriptan succinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on salmeterol xinafoate and sumatriptan succinate (the active ingredients of Serevent and Sumatriptan succinate, respectively), and Serevent and Sumatriptan succinate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: